Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-185-5 | CAS number: 1310-73-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Direct observations: clinical cases, poisoning incidents and other
Administrative data
- Endpoint:
- direct observations: clinical cases, poisoning incidents and other
- Type of information:
- other: case report
- Adequacy of study:
- supporting study
- Reliability:
- 3 (not reliable)
- Rationale for reliability incl. deficiencies:
- other: Clinical observation of a 42-year-old depressed female who swallowed 30 ml of a 16% sodium hydroxide solution.
Data source
Reference
- Reference Type:
- publication
- Title:
- Gastric Antral Patch Esophagoplasty for Extensive Corrosive Stricture of the Esophagus
- Author:
- Hugh et al.
- Year:
- 1 991
- Bibliographic source:
- World J Surg 15, 299-303
Materials and methods
- Study type:
- other: suicidal ingestion
- Endpoint addressed:
- not applicable
- Principles of method if other than guideline:
- A case is reported of a patient with a 9-cm stricture of the esophagus caused by ingestion of sodium hydroxide, who was treated by gastric antral patch esophagoplasty.
- GLP compliance:
- no
Test material
- Reference substance name:
- Sodium hydroxide
- EC Number:
- 215-185-5
- EC Name:
- Sodium hydroxide
- Cas Number:
- 1310-73-2
- Molecular formula:
- HNaO
- IUPAC Name:
- sodium hydroxide
- Details on test material:
- - Name of test material (as cited in study report): "Drano", sodium hydroxide solution
- Physical state: sodium hydroxide solution
Constituent 1
Method
- Type of population:
- other: one case, 42-year-old female
- Subjects:
- - Number of subjects exposed: 1
- Sex: female
- Age: 42 year
- Known diseases: depression
- Other: She was 12-16 weeks pregnant at the time, and had previously been in good health and free of any digestive symptoms - Ethical approval:
- not applicable
- Route of exposure:
- oral
- Reason of exposure:
- intentional
- Exposure assessment:
- not specified
- Details on exposure:
- A 42-year-old depressed female swallowed approximately 30 ml of "Drano", a 16% sodium hydroxide solution, in a suicide attempt.
- Examinations:
- - Other: a number of endoscopic examinations; barium X-ray studies
- Medical treatment:
- Dilatations of the esophagus, and a feeding jejunostomy was established. A termination of pregnancy and tubal ligation was carried out. Further dilatations were performed, some of which were abandoned, and during one of which an apparent perforation of the esophagus occurred. This complication was treated conservatively, although a laparotomy was done because of suspected peritonitis. Although it was knon from the previous laparotomy findings that there was considerable scarring in the stomach, the patient's condition was considered to be suitable for a gastric antral patch esophagoplasty (GAPE) provided sufficient supple gastric wall could be obtained.
Results and discussion
- Results of examinations:
- - Other: Barium X-ray studies showed a stricture 9 cm in length in the body of the esophagus, commencing above the level of the tracheal bifurcation, and extending to just above the diaphragm. At endoscopy, a pharyngeal web was noted at the level of the epiglottis, the latter structure apperently having been complety destroyed. A standard-sized endoscope could just be passed alongside a small endotracheal tube. There was slight stenosis at the level of the cricopharyngeal sphincter, and a very tight esophageal stricutre was encountered at 22 cm from the incisor teeth; no identifiable lumen was present at this level.
- Effectivity of medical treatment:
- After leaving the hospital (gastric antral patch esophagoplasty for extensive corrosive stricture of the esophagus), the patient noted occasional sticking of solid food in the pharyngeal region, and endoscopy 8 weeks post-operatively showed some stenosis at the level of the cricopharyngeus muscle, where a slight stricture had previously been encountered. This was dilated readily, and the remainder of the esophageal lumen was found to be normal in caliber. A further endoscopy 6 months postoperatively showed the esophagus to have a normal sized lumen. The lining of the patch had the appearance of healthy gastric mucosa. the patient had continued to eat normally, without the need for futher dilatations during a follow-up period of 15 months. Serum gastrin levels have remained normal, indicating that the patch is nog producing excessive amounts of this hormone. Manometric and esophageal pH monitoring studies were done 8 weeks after operation. Manometry was performed with a dent sleeve attached to low compliance capillary perfusion apparatus. Postoperative 24 hour pH monitoring was carried out using an antimony probe connected to a Synectics "Digitrapper", the probe tip being placed 5 cm proximal to the manometrically idntified high-pressure zone. There were very few reflux episodes, and such episodes were entirely absent during sleep.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.